πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,301 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10280414

Stabilized Ξ±-galactosidase and uses thereof

Protalix Ltd. Β· Granted Tue May 07 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 02 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10266496

Carboxy substituted (hetero) aromatic ring derivatives and preparation method and uses the

SUNSHINE LAKE PHARMA CO., LTD. Β· Granted Tue Apr 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10266579

Synthetic somatostatin receptor ligands

TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. Β· Granted Tue Apr 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10266521

Substituted heteroaryl compounds and methods of use

SUNSHINE LAKE PHARMA CO., LTD. Β· Granted Tue Apr 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10265337

Use of A3 adenosine receptor agonist in osteoarthritis treatment

CAN-FITE BIOPHARMA LTD. Β· Granted Tue Apr 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10251923

Therapeutic uses of mastic gum fractions

REGENERA PHARMA LTD. Β· Granted Tue Apr 09 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10246508

Anti eotaxin-2 antibodies that recognize additional CCR3-binding chemokines

CHEMOMAB LTD. Β· Granted Tue Apr 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10238710

Peptide having anti-inflammatory, osteogenic and hair growth promoting activities, and use

CAREGEN CO., LTD. Β· Granted Tue Mar 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10238606

Pharmaceutical compositions for the treatment of Helicobacter pylori

RedHill Biopharma Ltd. Β· Granted Tue Mar 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10226420

Methods of eye treatment using therapeutic compositions containing dipyridamole

O.D. Ocular Discovery Ltd. Β· Granted Tue Mar 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10214721

Method for making culture medium

HON HAI PRECISION INDUSTRY CO., LTD. Β· Granted Tue Feb 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10196383

Substituted quinazoline compounds and preparation and uses thereof

SUNSHINE LAKE PHARMA CO., LTD. Β· Granted Tue Feb 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10183917

Tricyclic compounds and uses thereof in medicine

SUNSHINE LAKE PHARMA CO., LTD. Β· Granted Tue Jan 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10179151

Methods of transdifferentiation and methods of use thereof

TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. Β· Granted Tue Jan 15 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10166219

Formulations and methods of manufacturing formulations for use in colonic evacuation

RedHill Biopharma Ltd. Β· Granted Tue Jan 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10167292

Benzodiazepines as bromodomain inhibitors

Catalyst Therapeutics Pty Ltd. Β· Granted Tue Jan 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10159703

Traditional chinese medicine composition for relieving chronic pain and preparation method

INFINITUS (CHINA) COMPANY LTD. Β· Granted Tue Dec 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10159680

Compositions comprising acidic extracts of mastic gum

REGENERA PHARMA LTD. Β· Granted Tue Dec 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10143702

Fixed-dose pharmaceutical composition comprising rifabutin, clarithromycin, and clofazimin

RedHill Biopharma Ltd. Β· Granted Tue Dec 04 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10143636

Porous silica particle and cleansing cosmetic

JGC Catalysts and Chemicals Ltd. Β· Granted Tue Dec 04 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10138255

Piperazine derivatives as HIV protease inhibitors

MSD R&D (China) Co. Ltd. Β· Granted Tue Nov 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10130621

Analogs of pridopidine, their preparation and use

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Nov 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10130080

Obesity animal model and methods for making and using thereof

PERFECT (CHINA) CO., LTD. Β· Granted Tue Nov 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10125139

Pesticidally active polycyclic derivatives with sulfur substituted five-membered ring hete

SYNGENTA (CHINA) INVESTMENT CO. LTD. Β· Granted Tue Nov 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted